Catalent Net Income 2012-2020 | CTLT

Catalent annual/quarterly net income history and growth rate from 2012 to 2020. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Catalent net income for the quarter ending March 31, 2020 was $0.012B, a 62.78% decline year-over-year.
  • Catalent net income for the twelve months ending March 31, 2020 was $0.109B, a 26.71% decline year-over-year.
  • Catalent annual net income for 2019 was $0.137B, a 64.35% increase from 2018.
  • Catalent annual net income for 2018 was $0.084B, a 23.86% decline from 2017.
  • Catalent annual net income for 2017 was $0.11B, a 1.52% decline from 2016.
Catalent Annual Net Income
(Millions of US $)
2019 $137
2018 $84
2017 $110
2016 $112
2015 $212
2014 $16
2013 $-50
2012 $-24
2011 $-54
Catalent Quarterly Net Income
(Millions of US $)
2020-03-31 $12
2019-12-31 $34
2019-09-30 $-8
2019-06-30 $71
2019-03-31 $32
2018-12-31 $49
2018-09-30 $-14
2018-06-30 $83
2018-03-31 $19
2017-12-31 $-22
2017-09-30 $4
2017-06-30 $62
2017-03-31 $26
2016-12-31 $17
2016-09-30 $5
2016-06-30 $58
2016-03-31 $11
2015-12-31 $31
2015-09-30 $12
2015-06-30 $154
2015-03-31 $32
2014-12-31 $47
2014-09-30 $-20
2014-06-30 $27
2014-03-31 $7
2013-12-31 $-19
2013-09-30 $2
2013-06-30
2013-03-31
2012-06-30
2011-06-30
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $12.084B $2.518B
Catalent, Inc. provides advanced delivery technologies and development solutions for drugs, biologics and consumer health products. It operates through Oral Technologies, Medication Delivery Solutions, and Development & Clinical Services. The Oral Technologies segment address the full diversity of the pharmaceutical industry including small molecules, large molecule biologics and consumer health products. The Medication Delivery Solutions segment offers formulation, development, and manufacturing services for delivery of drugs and biologics administered through injection, inhalation, and ophthalmic routes. The Development and Clinical Services segment provides manufacturing, packaging, storage, and inventory management services for drugs and biologics in clinical trials. Catalent, Inc. is headquartered in Somerset, New Jersey.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $65.114B 36.95
Takeda Pharmaceutical (TAK) Japan $54.448B 9.54
Astellas Pharma (ALPMY) Japan $29.844B 0.00
Eisai (ESALY) Japan $24.126B 20.91
UCB SA (UCBJF) Belgium $23.749B 0.00
Merck (MKGAF) Germany $16.013B 0.00
Grifols, S.A (GRFS) Spain $12.761B 15.86
Neurocrine Biosciences (NBIX) United States $12.044B 55.66
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $9.945B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 0.00
Ionis Pharmaceuticals (IONS) United States $8.650B 45.99
IPSEN SA ADR (IPSEY) France $7.290B 0.00
Orion OYJ (ORINY) Finland $7.077B 31.71
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.664B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $5.900B 9.44
United Therapeutics (UTHR) United States $5.169B 9.79
STADA ARZNEIMI (STDAF) Germany $4.916B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $4.530B 494.56
Nektar Therapeutics (NKTR) United States $4.276B 0.00
Evotec AG (EVTCY) Germany $4.040B 108.88
Hypermarcas (HYPMY) Brazil $3.840B 14.12
FibroGen (FGEN) United States $3.722B 0.00
ChemoCentryx (CCXI) United States $3.693B 0.00
PTC Therapeutics (PTCT) United States $3.600B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.492B 10.24
Pacira BioSciences (PCRX) United States $2.435B 49.83
Sage Therapeutics (SAGE) United States $2.228B 0.00
Cronos Group (CRON) Canada $2.205B 63.20
Corcept Therapeutics (CORT) United States $1.890B 18.74
Xencor (XNCR) United States $1.817B 0.00
USANA Health Sciences (USNA) United States $1.729B 17.74
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.677B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.571B 12.02
Akebia Therapeutics (AKBA) United States $1.561B 0.00
Indivior (INVVY) United States $1.523B 18.91
Zogenix (ZGNX) United States $1.507B 0.00
Heron Therapeutics (HRTX) United States $1.429B 0.00
Esperion Therapeutics (ESPR) United States $1.410B 0.00
Karyopharm Therapeutics (KPTI) United States $1.402B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.392B 15.00
Theravance Biopharma (TBPH) Cayman Islands $1.364B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.200B 0.00
Translate Bio (TBIO) United States $1.069B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.024B 45.70
Tilray (TLRY) Canada $1.000B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.959B 0.00
Endo (ENDP) Ireland $0.790B 1.22
ImmunoGen (IMGN) United States $0.753B 0.00
Aerie Pharmaceuticals (AERI) United States $0.619B 0.00
Radius Health (RDUS) United States $0.618B 0.00
Trillium Therapeutics (TRIL) Canada $0.606B 0.00
VAXART, INC (VXRT) United States $0.592B 0.00
Molecular Templates (MTEM) United States $0.591B 0.00
Collegium Pharmaceutical (COLL) United States $0.574B 0.00
Ardelyx (ARDX) United States $0.571B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.557B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.511B 12.35
Crinetics Pharmaceuticals (CRNX) United States $0.502B 0.00
Innate Pharma SA (IPHYF) France $0.497B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.464B 18.11
Flexion Therapeutics (FLXN) United States $0.462B 0.00
Siga Technologies (SIGA) United States $0.462B 0.00
DURECT (DRRX) United States $0.412B 0.00
TherapeuticsMD (TXMD) United States $0.408B 0.00
Harpoon Therapeutics (HARP) United States $0.406B 0.00
Ocular Therapeutix (OCUL) United States $0.396B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.389B 0.00
Organogenesis Holdings (ORGO) United States $0.366B 0.00
Calithera Biosciences (CALA) United States $0.363B 0.00
MEI Pharma (MEIP) United States $0.352B 0.00
Altimmune (ALT) United States $0.347B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.300B 0.00
Concert Pharmaceuticals (CNCE) United States $0.299B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.298B 0.00
PROFOUND MEDICL (PROF) Canada $0.288B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.248B 0.00
Taiwan Liposome (TLC) Taiwan $0.241B 0.00
Redhill Biopharma (RDHL) Israel $0.238B 0.00
CASI Pharmaceuticals (CASI) United States $0.235B 0.00
Lannett Co Inc (LCI) United States $0.232B 5.08
KalVista Pharmaceuticals (KALV) United States $0.220B 0.00
Rafael Holdings (RFL) United States $0.204B 0.00
Jounce Therapeutics (JNCE) United States $0.201B 4.80
OptiNose (OPTN) United States $0.189B 0.00
Nivalis Therapeutics (ALPN) United States $0.182B 0.00
IMV INC (IMV) Canada $0.182B 0.00
Nature's Sunshine Products (NATR) United States $0.181B 23.80
Aquestive Therapeutics (AQST) United States $0.144B 0.00
Otonomy (OTIC) United States $0.130B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.129B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.118B 0.00
Champions Oncology (CSBR) United States $0.116B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.102B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.101B 0.00
Xeris Pharmaceuticals (XERS) United States $0.099B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.099B 0.00
Recro Pharma (REPH) United States $0.098B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.096B 0.00
MediWound (MDWD) Israel $0.096B 0.00
Onconova Therapeutics (ONTX) United States $0.096B 0.00
CTI BioPharma (CTIC) United States $0.090B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.089B 0.00
Biomerica (BMRA) United States $0.088B 0.00
Sundial Growers (SNDL) Canada $0.087B 0.00
Heat Biologics (HTBX) United States $0.086B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.085B 0.00
Aclaris Therapeutics (ACRS) United States $0.083B 0.00
SCYNEXIS (SCYX) United States $0.070B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.066B 0.00
Lipocine (LPCN) United States $0.064B 0.00
CV Sciences (CVSI) United States $0.061B 0.00
Addex Therapeutics (ADXN) Switzerland $0.057B 0.00
RENEURON GP (RNUGF) United Kingdom $0.057B 0.00
Infinity Pharmaceuticals (INFI) United States $0.056B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.048B 28.91
PolarityTE (PTE) United States $0.047B 0.00
Natural Alternatives (NAII) United States $0.046B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.043B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.043B 0.00
Forward Pharma (FWP) Denmark $0.042B 0.00
Mannatechorporated (MTEX) United States $0.042B 7.87
Jaguar Animal Health (JAGX) United States $0.041B 0.00
Novan (NOVN) United States $0.041B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.040B 86.09
Bellicum Pharmaceuticals (BLCM) United States $0.037B 0.00
GTx (ONCT) United States $0.034B 0.00
ElectroCore (ECOR) United States $0.032B 0.00
Neos Therapeutics (NEOS) United States $0.032B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.026B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.023B 0.00
Iterum Therapeutics (ITRM) Ireland $0.021B 0.00
Flex Pharma (SLRX) United States $0.020B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
ProPhase Labs (PRPH) United States $0.018B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.018B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
China SXT Pharmaceuticals (SXTC) China $0.015B 0.00
Cyanotech (CYAN) United States $0.014B 34.00
Shineco (TYHT) China $0.014B 0.00
RXi Pharmaceuticals (PHIO) United States $0.013B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.011B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.010B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Vical (BBI) United States $0.009B 0.00
Midatech Pharma (MTP) United Kingdom $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00